About CytoReason

CytoReason has developed the first machine learning model of the immune system. The technology is based on over a decade of research at Stanford and the Technion. Our model leverages literature and measurement data from public and proprietary sources. We partner with top-pharma and research-institutions, de-risking their research while training our model. These collaborations span discovery, development and post-market stages by identifying biomarkers, modeling compound’s mode of action, and disease research. Our work is supporting patient stratification, companion diagnostics, prediction of adverse events and indication expansion.

Facts about CytoReason
  • Founding: 2016
  • Focus : Service
  • Employees: 11-50
  • Industry : Biotechnology

Product portfolio of CytoReason

Product portfolio

Here you will find CytoReason Ltd.